The ONLY Global Cell and Gene facilities database subscription that actively tracks over 200+ dedicated Cell and Gene Therapy facilities providing cell therapy and gene therapy development and manufacturing services for biopharmaceuticals.
Global cell and gene therapy market size is projected to reach approximately $82.24 billion by 2032.
CONCENTRATION OF GLOBAL CELL AND GENE THERAPY BIOPHARMACEUTICAL MANUFACTURING
Current Count of Cell and Gene Facilities: 339.
Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updated continually and includes comprehensive information and insights.
"Top200Cell and Gene Facility Index" ranks each 'dedicated' cell and gene therapy facility and provides regional quantitative analysis of biomanufacturing regions and clusters.
Total bioreactor liter capacity
Cell and Gene Therapy service expertise
Future Biomanufacturing capacity coming online
Number of commercial and clinical biological products manufactured
Revenue estimates
Strengths and Challenges
Technologies and expertise, and much more
WHAT YOU'LL GET:
Full 1 year Subscription
Biofacilities Quarterly Newsletter (Free!)
Dashboard: Searchable and sortable
Regular database updates
Optional: Access to live analysts for queries and input
USES FOR THE TOP200CellGene.COM
Identify ideal partners: develop key networks with CT/GT partners
Identify specialized expertise: cell or gene therapy, pDNA, mRNA
Early-stage companies: sponsors can identify potential manufacturing partners